3 app risk simulation(s): 1 safe, 1 review, 0 high risk, 1 blocked.
Avg Risk
49%
Safe
1
Review
1
High Risk
0
Blocked
1
Critical
2
Web, API · contact sales · 410 installs
InboxLab is block rollout with 100% risk and 2 blocker(s).
Permission scope · 24
Security review · 34
Runtime health · 30
Privacy labels · 14
Docs/support · 8
Release package · 10
Creator trust · 0
License impact · 8
Blockers
Security is rejected with critical risk. Runtime is maintenance.
Web, Mobile, Extension · freemium · 920 installs
Anslation Builder is manager review with 48% risk and 0 blocker(s).
Permission scope · 10
Security review · 16
Runtime health · 12
Privacy labels · 0
Docs/support · 0
Release package · 10
Creator trust · 0
License impact · 0
Scenario
Default risk view for shared workspace adoption.
Risk Lanes
Blocked
Apps with runtime, security, or critical scope blockers.
High Risk
Apps that need security owner review before rollout.
Review Needed
Apps needing manager, finance, permission, or rollout review.
Safe To Launch
Apps with low risk for pilot or controlled rollout.
Signal Coverage
Creator trust
0% risk
Docs/support
33% risk
License impact
33% risk
Permission scope
67% risk
Privacy labels
33% risk
Release package
67% risk
Runtime health
67% risk
Security review
67% risk
Mitigation Queue
Reduce or approve permission scope
InboxLab
Run security review
InboxLab
Fix runtime health
InboxLab
Complete evidence packet
InboxLab
Confirm license and spend owner
InboxLab
Reduce or approve permission scope
Anslation Builder